TrialKidney international2019

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

David M Charytan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.